Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Schnaidt

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
Journal of the American Heart Association|April 14, 2017
Statin Eligibility and Outpatient Care Prior to ST-Segment Elevation Myocardial InfarctionMichael D Miedema, Ross F Garberich, Lucas J Schnaidt, et al.
Diabetes Care|August 11, 2019
Effect of Linagliptin on Cognitive Performance in Patients With Type 2 Diabetes and Cardiorenal Comorbidities: The CARMELINA Randomized TrialGeert Jan Biessels, Chloë Verhagen, Jolien Janssen, et al.
Annals of Surgery|March 29, 2019
Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic CancerUlla Klaiber, Eva S Schnaidt, Ulf Hinz, et al.
BMC Primary Care|February 28, 2025
Experiences of general practice teams and their patients with clinical research-a mixed-methods process evaluation of the Bavarian Research Practice Network (BayFoNet)Linda Sanftenberg, Anna-Lena Schnaidt, Stefanie Eck, et al.
Circulation|June 28, 2022
Empagliflozin for Heart Failure With Preserved Left Ventricular Ejection Fraction With and Without DiabetesGerasimos Filippatos, Javed Butler, Dimitrios Farmakis, et al.
British Journal of Haematology|March 23, 2011
Expression of blood group genes by mesenchymal stem cellsRichard Schäfer, Martina Schnaidt, Roland A Klaffschenkel, et al.
International Journal of Cancer|January 23, 2013
Exploring the association between genetic variation in the SUMO isopeptidase gene USPL1 and breast cancer through integration of data from the population-based GENICA study and external genetic databasesJusto Lorenzo Bermejo, Maria Kabisch, Thomas Dünnebier, et al.
JAMA Cardiology|January 3, 2024
Hypoglycemia and Cardiovascular Outcomes in the CARMELINA and CAROLINA Trials of Linagliptin: A Secondary Analysis of Randomized Clinical TrialsNikolaus Marx, Ahmed A Kolkailah, Julio Rosenstock, et al.
Plos One|April 7, 2015
Alpha-synuclein levels in blood plasma decline with healthy agingNiklas K U Koehler, Elke Stransky, Mirjam Meyer, et al.
Diabetology International|March 25, 2020
Linagliptin and cardiorenal outcomes in Asians with type 2 diabetes mellitus and established cardiovascular and/or kidney disease: subgroup analysis of the randomized CARMELINA<sup>®</sup> trialNobuya Inagaki, Wenying Yang, Hirotaka Watada, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Journal of the American Heart Association|April 14, 2017
Statin Eligibility and Outpatient Care Prior to ST-Segment Elevation Myocardial InfarctionMichael D Miedema, Ross F Garberich, Lucas J Schnaidt, et al.
Diabetes Care|August 11, 2019
Effect of Linagliptin on Cognitive Performance in Patients With Type 2 Diabetes and Cardiorenal Comorbidities: The CARMELINA Randomized TrialGeert Jan Biessels, Chloë Verhagen, Jolien Janssen, et al.
Annals of Surgery|March 29, 2019
Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic CancerUlla Klaiber, Eva S Schnaidt, Ulf Hinz, et al.
BMC Primary Care|February 28, 2025
Experiences of general practice teams and their patients with clinical research-a mixed-methods process evaluation of the Bavarian Research Practice Network (BayFoNet)Linda Sanftenberg, Anna-Lena Schnaidt, Stefanie Eck, et al.
Circulation|June 28, 2022
Empagliflozin for Heart Failure With Preserved Left Ventricular Ejection Fraction With and Without DiabetesGerasimos Filippatos, Javed Butler, Dimitrios Farmakis, et al.
British Journal of Haematology|March 23, 2011
Expression of blood group genes by mesenchymal stem cellsRichard Schäfer, Martina Schnaidt, Roland A Klaffschenkel, et al.
International Journal of Cancer|January 23, 2013
Exploring the association between genetic variation in the SUMO isopeptidase gene USPL1 and breast cancer through integration of data from the population-based GENICA study and external genetic databasesJusto Lorenzo Bermejo, Maria Kabisch, Thomas Dünnebier, et al.
JAMA Cardiology|January 3, 2024
Hypoglycemia and Cardiovascular Outcomes in the CARMELINA and CAROLINA Trials of Linagliptin: A Secondary Analysis of Randomized Clinical TrialsNikolaus Marx, Ahmed A Kolkailah, Julio Rosenstock, et al.
Plos One|April 7, 2015
Alpha-synuclein levels in blood plasma decline with healthy agingNiklas K U Koehler, Elke Stransky, Mirjam Meyer, et al.
Diabetology International|March 25, 2020
Linagliptin and cardiorenal outcomes in Asians with type 2 diabetes mellitus and established cardiovascular and/or kidney disease: subgroup analysis of the randomized CARMELINA<sup>®</sup> trialNobuya Inagaki, Wenying Yang, Hirotaka Watada, et al.
Pageof 9